• CCO
• Oncology
• Live Events
• Lymphoproliferative Disease

Friday, May 30, 2008
Hilton Chicago
Grand Ballroom, 2nd Floor
Chicago, Illinois

Thank you for your interest in this live program. Registration is closed, as the current schedule has been completed. Please email info@clinicaloptions.com for more information.

This independent satellite symposium will discuss the pathogenesis and progression of lymphoproliferative disease. Data will also be presented from key clinical trials evaluating current and investigational therapeutic options.

This presentation was selected by the American Society of Clinical Oncology^® as an independent educational activity held adjunct to the ASCO Annual Meeting. This presentation is not sponsored or endorsed by ASCO.

• Agenda
• Faculty
• CME Information
• Accreditation

Event Date	Details
Friday, May 30, 2008	6:00 PM - 8:30 PM Local Time Registration and Dinner 6:00 PM - 6:30 PM Symposium 6:30 PM - 8:30 PM

Agenda

Welcome and Introduction
Alexandra M. Levine, MD

Pathogenesis and Progression of Lymphoproliferative Disease:  Evolving Concepts
Alexandra M. Levine, MD

Cytotoxic Chemotherapy in a Time of Change 
Julie M. Vose, MD

Monoclonal Antibodies in Lymphoproliferative Disorders: From Rationale to Results
Jonathan W. Friedberg, MD

Targeted Therapies in Lymphoproliferative Disease: Today and Tomorrow
Michael J. Keating, MB BS

Debate Session
Strategic Approaches to Therapy: Advances and Challenges
Moderator: Alexandra M. Levine, MD

Question and Answer Session
Moderator: Alexandra M. Levine, MD

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.